Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 144

1.

A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.

Dentice RL, Elkins MR, Middleton PG, Bishop JR, Wark PA, Dorahy DJ, Harmer CJ, Hu H, Bye PT.

Thorax. 2016 Feb;71(2):141-7. doi: 10.1136/thoraxjnl-2014-206716.

PMID:
26769016
2.

The Influence of Nebulized Drugs on Nasal Ciliary Activity.

Boon M, Jorissen M, Jaspers M, Augustijns P, Vermeulen FL, Proesmans M, De Boeck K.

J Aerosol Med Pulm Drug Deliv. 2016 Jan 7. [Epub ahead of print]

PMID:
26741301
3.

Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Welsh EJ, Evans DJ, Fowler SJ, Spencer S.

Cochrane Database Syst Rev. 2015 Jul 14;7:CD010337. doi: 10.1002/14651858.CD010337.pub2. Review.

PMID:
26171905
4.

Hyper-osmolarity and calcium chelation: Effects on cystic fibrosis mucus.

Ermund A, Meiss LN, Gustafsson JK, Hansson GC.

Eur J Pharmacol. 2015 Oct 5;764:109-17. doi: 10.1016/j.ejphar.2015.06.051. Epub 2015 Jun 30.

PMID:
26134505
5.

Duration of action of hypertonic saline on mucociliary clearance in the normal lung.

Bennett WD, Wu J, Fuller F, Balcazar JR, Zeman KL, Duckworth H, Donn KH, O'Riordan TG, Boucher RC, Donaldson SH.

J Appl Physiol (1985). 2015 Jun 15;118(12):1483-90. doi: 10.1152/japplphysiol.00404.2014. Epub 2015 Apr 24.

PMID:
25911685
6.

Recent advances in cystic fibrosis.

Milla CE, Moss RB.

Curr Opin Pediatr. 2015 Jun;27(3):317-24. doi: 10.1097/MOP.0000000000000226. Review.

PMID:
25888148
7.

Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Main E, Grillo L, Rand S.

Semin Respir Crit Care Med. 2015 Apr;36(2):251-66. doi: 10.1055/s-0035-1546820. Epub 2015 Mar 31.

PMID:
25826592
8.

Therapeutic options for hydrating airway mucus in cystic fibrosis.

Tildy BE, Rogers DF.

Pharmacology. 2015;95(3-4):117-32. doi: 10.1159/000377638. Epub 2015 Mar 19. Review.

9.

New therapeutic options for noncystic fibrosis bronchiectasis.

Yap VL, Metersky ML.

Curr Opin Infect Dis. 2015 Apr;28(2):171-6. doi: 10.1097/QCO.0000000000000147. Review.

PMID:
25692269
10.

Alternative outcomes for the multiple breath washout in children with CF.

Stanojevic S, Jensen R, Sundaralingam D, Salazar JG, Yammine S, Singer F, Latzin P, Amin R, Subbarao P, Gustafsson P, Ratjen F.

J Cyst Fibros. 2015 Jul;14(4):490-6. doi: 10.1016/j.jcf.2014.12.008. Epub 2015 Jan 8.

PMID:
25578856
11.

Guanylin activates Cl(-) secretion into the lumen of seawater eel intestine via apical Cl(-) channel under simulated in vivo conditions.

Ando M, Takei Y.

Am J Physiol Regul Integr Comp Physiol. 2015 Mar 1;308(5):R400-10. doi: 10.1152/ajpregu.00333.2014. Epub 2014 Dec 24.

12.

Hyperosmolarity invokes distinct anti-inflammatory mechanisms in pulmonary epithelial cells: evidence from signaling and transcription layers.

Wright FL, Gamboni F, Moore EE, Nydam TL, Mitra S, Silliman CC, Banerjee A.

PLoS One. 2014 Dec 5;9(12):e114129. doi: 10.1371/journal.pone.0114129. eCollection 2014.

13.

Initial evaluation of the Parent Cystic Fibrosis Questionnaire--Revised (CFQ-R) in infants and young children.

Alpern AN, Brumback LC, Ratjen F, Rosenfeld M, Davis SD, Quittner AL.

J Cyst Fibros. 2015 May;14(3):403-11. doi: 10.1016/j.jcf.2014.11.002. Epub 2014 Nov 28.

PMID:
25443473
14.

A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in cystic fibrosis.

Markovetz MR, Corcoran TE, Locke LW, Myerburg MM, Pilewski JM, Parker RS.

PLoS One. 2014 Nov 10;9(11):e111972. doi: 10.1371/journal.pone.0111972. eCollection 2014.

15.

Hypertonic saline releases the attached small intestinal cystic fibrosis mucus.

Ermund A, Meiss LN, Scholte BJ, Hansson GC.

Clin Exp Pharmacol Physiol. 2015 Jan;42(1):69-75. doi: 10.1111/1440-1681.12322.

16.

Children and young adults with CF in the USA have better lung function compared with the UK.

Goss CH, MacNeill SJ, Quinton HB, Marshall BC, Elbert A, Knapp EA, Petren K, Gunn E, Osmond J, Bilton D.

Thorax. 2015 Mar;70(3):229-36. doi: 10.1136/thoraxjnl-2014-205718. Epub 2014 Sep 25.

17.

The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?

Bilton D, Stanford G.

Curr Opin Pulm Med. 2014 Nov;20(6):601-6. doi: 10.1097/MCP.0000000000000104. Review.

PMID:
25221855
18.

Fifteen-year-old girl with severe obstructive lung disease, pansinusitis, and failure to thrive.

Taylor MK, McCauley LA, Alexander CK, Laguna TA.

Clin Pediatr (Phila). 2014 Sep;53(10):1016-8. doi: 10.1177/0009922814533417. Epub 2014 May 9. No abstract available.

PMID:
24817075
19.

[Inhaled treatments in cystic fibrosis: what's new in 2013?].

Dubus JC, Bassinet L, Chedevergne F, Delaisi B, Desmazes-Dufeu N, Reychler G, Vecellio L; GRAM (Groupe aérosols et mucoviscidose de la Société française de mucoviscidose).

Rev Mal Respir. 2014 Apr;31(4):336-46. doi: 10.1016/j.rmr.2013.12.001. Epub 2014 Jan 4. Review. French.

PMID:
24750953
20.

Sodium channel blockers for cystic fibrosis.

Burrows EF, Southern KW, Noone PG.

Cochrane Database Syst Rev. 2014 Apr 9;4:CD005087. doi: 10.1002/14651858.CD005087.pub4. Review.

PMID:
24715704
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk